In pregnancies complicated by maternal obesity and GDM, there is evidence to suggest that the insulin signaling pathway in the placenta may be impaired and may contribute to changes in the metabolic programming of the offspring [26,28,29,30,31,32]. The gene discussed is INS; the disease is gestational diabetes.